Clinical Trial Update: The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy of fulvestrant in ESR1-mutated metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN